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Abstract 
 
This first worldwide interlaboratory study on the determination of perfluorinated compounds (PFCs) in 
environmental and human matrices was conducted in 2005. The main objective was to assess the between-
laboratory reproducibility for various PFCs in a number of matrices: fish muscle tissue, freshwater, human 
plasma and whole blood. In addition, a standard solution and a clean fish extract were included in the study 
to evaluate instrumental and quantitation performance. Thirty-eight laboratories from 13 countries 
participated in the analysis of one or several matrices. 
 
There are various challenges in the development of accurate analytical methods for the detection of PFCs. 
Factors like sample extraction, instrumentation, quantitation and level of experience were taken into 
consideration when interpreting the results of this study. The participating laboratories agreement with each 
other and their ability to estimate a true value was evaluated. The data of this study was evaluated by 
determination of z-scores according to the Cofino model. 
 
In general, the level of agreement between the participating laboratories decreased with increasing 
complexity of the matrix. Relatively good agreement between the laboratories was obtained for the study 
standard, the fish extract, the whole blood and plasma sample. On the other hand little agreement was 
obtained for the fish tissue and the water sample. Extraction and clean-up showed large effects on the 
results for the more difficult matrices. 
 
Although much information was gained from this first interlaboratory study, a second interlaboratory study 
is recommended to further improve the PFC data quality. That study will possibly be organised in early 
2006.   
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1. Introduction and aim 
 
Perfluorinated organic compounds (PFCs) are a new class of environmental contaminants which are 
ubiquitous both in environmental and human samples (Van de Vijver et al., 2003; Kannan et al., 2004; Tomy 
et al., 2004).  
Large knowledge gaps exist in the many aspects of these contaminants such as toxicity, human intake, 
exposure and so on. To answer these research questions, analytical techniques for the accurate detection 
of these compounds must be available. 
The accurate and reproducible analysis of PFCs in human and environmental tissue is a challenge in many 
ways (Martin et al., 2004). Extraction and quantification methods, matrices analysed and use of (internal) 
standards vary between laboratories. Many factors, such as contamination from laboratory materials, 
incomplete recoveries and leakage from instrumental parts are common problems, and lead to poor 
accuracy, sensitivity and reproducibility. Due to their physical and chemical properties PFCs may stick to 
surfaces, and may be lost at any stage of the sample handling. Today LC-MS electrospray is the most 
common detection technique used in PFC analysis. A known difficulty with this technique is ion-suppression, 
both from the matrix and from poorly separated PFCs. Branched isomers challenge separation further, and 
reference standards are needed to assure the specificity of the data. 
The accuracy of the methods has only been tested in-house by spike experiments because up to date, no 
certified reference materials are available and no interlaboratory studies have been organized. The 1st 
world-wide interlaboratory study reported here was initiated to assess the quality of the analytical 
techniques applied by laboratories world wide.  
The Netherlands Institute for Fisheries Research (RIVO) and Man-Technology-Environment (MTM) Research 
Centre, Örebro University organized this 1st world-wide interlaboratory study in collaboration with the EU 
Perforce research project. The aim of this study is to acquire information on the level of agreement of the 
analytical methods employed for PFCs. This will lead to learn more about the accuracy of laboratories up till 
now in the detection of PFCs found in environmental and human samples, as well as to try to identify 
possible limitations of the methods. This study should allow further progress in the field.  
 
The objectives of this interlaboratory study were: 
 
• To determine the level of agreement between different laboratories, for each determinant within a 
given matrix (laboratory vs other laboratories) 
 
• To determine the level of agreement for different PFCs in the same matrix (determinant vs other 
determinants). 
 
• To determine the level of agreement for a determinant in different matrices. Hence to identify which 
matrices presented more difficulties (matrix vs matrix). 
 
Thirty-eight laboratories subscribed to this interlaboratory study out of which 31 indicated that they had the 
intention to participate in the EM part. Out of these 27 laboratories submitted results for one or more 
environmental matrices together with results for the standard with undisclosed concentrations. A total of 19 
laboratories entered the HM part of which 17 submitted results for the plasma sample. Only seven 
laboratories analysed and reported results for the whole blood sample. The participating laboratories can 
be found in Appendix 1. Submission of results from some laboratories was delayed and even withdrawn due 
to some reported technical problems or tight schedule. Registrations for the participation in environmental 
samples were from laboratories in Austria Belgium, Canada, Denmark, Germany, Italy, Japan, Norway, 
Sweden, Switzerland, The Netherlands, U.K. and USA. 
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2. Materials and methods 
2.1 Study design 
The analysis of PFCs in environmental (EM) and human matrices (HM) involves an extraction (and clean-up) 
step, followed by the final determination. These steps all contribute to the total variance associated with the 
final result. The interlaboratory study was developed in a way for the participants to determine possible 
sources of error in each step of analysis (extraction, calibration, final determination). This approach has 
shown to be valuable in earlier interlaboratory studies in e.g. brominated flame retardants and 
polychlorinated biphenyls (de Boer and Cofino, 2002) leading to improved performance of laboratories in 
subsequent interlaboratory studies. This approach has also been advocated by the former EU Bureau for 
Calibration and Reference materials (BCR) (Quevauviller and Maier, 1999). 
 
The following samples were supplied to the participants: 
• 1 ampoule with study standard (SS) (4 ml) 
• 1 ampoule with a fish liver extract (FLE) (3 ml) 
• 1 container with fish tissue (FT) (60 g) 
• 1 plastic bottle with water (1 L) 
• 1 container with human plasma (HP) (5-8 ml) 
• 1 container with human whole blood (HB) (~3 ml) 
 
The study standard with undisclosed concentrations was provided to participants for them to check the 
calibration of their instrument and the quality of their standards. A cleaned extract of a fish liver was 
provided in order to evaluate chromatographic separation and detection only (without interference from 
extraction and clean-up procedures). Finally, a spiked fish muscle tissue and naturally contaminated human 
whole blood and plasma were provided for evaluation of the complete procedure (including extraction and 
clean-up procedures).  
Laboratories were asked to analyse the samples using their in-house analytical methods.  
 
The following PFCs were targeted in this study: 
 
Full name of determinand Abbreviation 
Perfluorobutanoic acid PFBA 
Perfluorohexanoic acid PFHxA 
Perfluoroheptanoic acid PFHpA 
Perfluorooctanoic acid PFOA 
Perfluorononanoic acid PFNA 
Perfluorodecanoic acid PFDA 
Perfluoroundecanoic acid PFUnA 
Perfluorododecanoic acid PFDoA 
Perfluorobutane sulfonate PFBS 
Perfluorohexane sulfonate PFHxS 
Perfluorooctane sulfonate PFOS 
Perfluorodecane sulfonate PFDS 
Perfluorooctanesulfonamide PFOSA 
 
Details on the methods used by the participants are discussed in section 2.3. Submission of results was 
performed by means of electronic mail, pooled together and all converted to equivalent units for sample 
type. Statistical evaluation was performed using the Cofino Model to obtain the assigned value and z-scores 
to estimate the agreement between the various participants (see section 2.4).  
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Samples were prepared in house (see section 2.2) and sent to the participants (at ambient temperature) by 
courier TNT. Sample delivery time was between 2 to ca. 7 days. The participants were given ca. 3 months 
to analyze the samples and to submit their results and method details to the coordinator for statistical 
analysis. 
2.2 Materials provided 
RIVO was responsible for the production of the test materials of the EM part (water, study standard, FLE 
and fish muscle tissue), whereas MTM Research Centre was responsible for the HM part (human whole 
blood and human plasma). 
 
2.2.1 Study standard 
The SS was prepared as a solution of methanol to which the target compounds at undisclosed 
concentrations (in the range of 5-100 ng/ml) had been spiked. After homogenization, 4 ml of the study 
standard was ampouled in amber glass bottles. The actual concentrations of the targeted PFCs in the study 
standard are given in Table 2.  
 
2.2.2 Fish samples 
The FLE was prepared from livers from flounder (Platichthys flesus) originating from the Western Scheldt in 
The Netherlands. After mincing and homogenization of the liver tissue, the resulting homogenate was 
extracted batchwise according to a slightly modified method of (Giesy and Kannan, 2001). Subsequently, 
the lipids were removed from the extract by silica adsorption chromatography. The silica column (1.8 g) 
was loaded with the sample. The lipids (including PFOSA) were eluted by dichloromethane, whereas the 
target compounds (PFCAs and PFSAs) retained on the column. The target compounds were eluted by 
acetone. The acetone was subsequently replaced by methanol and an aliquot of the cleaned extract was 
analysed to determine the concentrations of the target compounds. The extract was subsequently spiked 
with the target compounds at concentrations mentioned in Table 2. After homogenization, ca. 3 ml of 
extract (equivalent to 1.5 gram fish liver) was ampouled.  
Stability analysis was carried out on the FLE. The extract was stored at room temperature (ca 20°C) and 
was analysed at day 1, 18 and 60. The data in Table 1 does not reveal a significant increase or decrease of 
PFOS and PFOA over time. 
 
Table 1. Stability data (room temperature) of PFOS and PFOA in the FLE. 
 Day PFOA PFOS 
RSD replicates (%, n=5) 1,18,60 11.8 5.4 
Average (ng/ml, n=2) 1 12.3 23.4 
Average (ng/ml, n=2) 18 11.9 24.9 
Single determination 60 12.7 23.0 
 
The FT sample was prepared from fillets of pike perch (Stizostedion lucioperca) caught in lake IJssel, The 
Netherlands. The muscle material was minced and thoroughly homogenized (after addition of 
butylhydroxytoluene as an antioxidant). Ca. 55 gram of homogenate was packed in a glass jar which is 
tightly closed to prevent leakage. The material was sterilized at 121°C and 3 bar for 30 minutes. 
Because of the very low levels of some of the target compounds in the fish material, some compounds 
were spiked prior to the homogenization step (see Table 2).  
The homogeneity of the material was tested by analysis of 10 lots from the complete batch, in duplicate. 
The parameters determined were PFOS and PFOA concentrations and moisture content. The relative 
standard deviation of these determinations was 7.9%, 3.5% and 0.24% respectively. ANOVA statistics 
revealed no significant difference between the lots and within a lot (i.e. duplicate analysis). The Snedecor F-
test did not show a statistically significant variance difference between the duplicates (within-lot 
homogeneity) and between the different lots (tested at 95 and 99% level). This shows that these PFCs are 
homogeneously distributed over the pike perch sample material. The relative standard deviation is low 
compared to the overall standard deviation for PFOS and PFOA found in this interlaboratory study. This 
shows that this material is very suitable for the use in this interlaboratory exercise. 
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Table 2. Concentrations of target compounds in the SS, spike concentrations in the FLE and the 
FT, including details on origin and purity of the compounds.  
Determinant Supplier Batch nr. Purity SS  (ng/ml) 
FLE*  
(ng/ml) 
FT*  
(ng/g) 
PFBA ABCR 131726? 99% 4.3 18 50 
PFHxA ABCR 1103-2C18-BS 98% 18 2.7 N.a. 
PFHpA N.a. N.a. N.a. N.a. N.a. N.a. 
PFOA Sigma-Aldrich 171468-25G 96% 8.4 11 9.7 
PFNA N.a. N.a. N.a. N.a. N.a. N.a. 
PFDA ABCR 1327-1B16 98% 14 14 N.a. 
PFUnA Sigma- Aldrich 00929KB 95% 17 2.1 N.a. 
PFDoA Acros 06623DB 95% 3.8 17 40 
PFBS**  Sigma-Aldrich Not specified Not specified 47 6.9 21 
PFHxS** Fluka Unknown >98% 24 19 22 
PFOS** Fluka 403884/1 >98% 33 45 4.4 
PFDS N.a. N.a. N.a. N.a. N.a. N.a. 
PFOSA ABCR 87-10-?? 97% 61 6.1 49 
* In addition to the traces of PFCs that were already present from natural contamination of the matrix 
** Potassium salt 
2.2.3 Water sample 
Hundred litres of naturally contaminated brackish water has been sampled from the North Sea canal, just 
outside the locks of IJmuiden, The Netherlands. The water was filtrated over 0.45 μm filter to remove 
particulate matter and stored in a 100 liter tank. Microbial activity was reduced by lowering the pH to ca. 2 
by addition of 0.5% (v/v) formic acid. The water was thoroughly homogenised and was continuously 
homogenized during dispersion into 1 litre brown HDPE 1 litre bottles. No homogeneity evaluation has been 
performed as the above mentioned procedure was considered to result in homogeneous samples (both 
within the bottle as well as between the bottles). Between bottling and dispatch, the samples have been 
stored at 4°C. The participants were advised, prior to subsampling, to re-homogenise the contents of the 
bottle by gentle manual shaking. 
2.2.4 Human samples 
Authentic plasma and whole blood samples, without addition of perfluorinated compounds, representing the 
current levels in the Swedish general population were used. The samples were provided and administrated 
by the University Hospital of Örebro (USÖ), Sweden, and released for medical use according to the 
regulations by the Swedish National Board for Health and Welfare. This includes negative test results for 
HIV1/2, HBs-Ag, HCV-Ak and Syphilis (VDRL). 
 
The plasma sample was taken by venipuncture. Citrate was added before centrifugation and removal of the 
cellular elements. The material were homogenized and divided into polypropylene tubes in approximately 7 
ml portions and thereafter kept at -20°C before shipment to the participants. The whole blood sample was 
taken by venipuncture and collected in a heparin treated container. The material were homogenized and 
divided into polypropylene tubes in approximately 3 ml portions and thereafter kept at -20°C before 
shipment to the participants. 
 
Short-term stability of the materials at room temperature as well as at elevated (37°) temperature was 
established. Samples were stored at a laboratory bench at approximately 20°C, and in a temperature 
regulated cabinet, at 37°C. Whole blood and plasma samples stored at 20°C were analyzed at day 0, 2, 9 
and resulted in PFOS variation coefficients (CV) between 1-14%. Corresponding variation for storage at 37° 
and analysis at day 0, 2, 9 was 13-16%. Also included in Table 3 is the reproducibility of the method used. 
Concentrations of PFOS, PFOA, PFNA and PFHxS were found stable at room temperature when compared 
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to method reproducibility and cold storage (-20°C). The CVs are in most cases lower than then the CVs of 
the method reproducibility, showing that no additional variation is generated as a result of the storage 
conditions. Unfrozen short-term storage was therefore found acceptable (i.e. shipment). When stored at 
elevated temperature (37°C) the materials, especially whole blood, became more viscous and an increased 
variation in concentrations could be seen for all four PFCs. Since volumetric sampling was applied (as part 
of the analytical method used) it cannot be ruled out that the variation can be due to uncertainty in the 
sample volume taken. It is therefore not recommended storing the samples at temperatures above room 
temperature (ca. 20°C), which results in a more viscous sample. Concentrations after three freeze and thaw 
cycles deviated from replicate determinations on a single occasion with –10% for PFHxS, 5% for PFOA, -3% 
for PFOS and –4% for PFNA. 
Homogeneity within and between tubes (n=3-8) varied with a coefficient of variation (CV) between 1-4 % for 
PFOS concentration in whole blood and plasma (Table 3).  
 
Table 3. Coefficient of variation (CV) for 4 PFCs in plasma and whole blood analyzed a) multiple 
times from the same tube, b) from different tubes, c) stored at 20°C between three analysis, d) 
stored at 37°C between three analysis, and e) stored at –20°C. 
 PFOS PFOA PFHxS PFNA 
Method reproducibilitya 10% 5.9% 6.3% 12% 
Interlaboratory whole blood     
  a) within tube (n=3) 1.4 % 2.1 % 3.4 % 19 % 
  b) between tubes (n=8) 4.3 % 3.3 % 4.3 % 6.4 % 
  c) storage 20°C 0,2,9 days  1.3 % 4.5 % 5.2 % 6.1 % 
  d) storage 37°C 0,2,9 days  13 % 7.6 % 14 % 42 % 
Whole blood, other batch     
  e) storage –20°C, 4 monthsb 12% 11% 12% 2% 
Interlaboratory plasma     
  a) within tube (n=3) 3.0 % 6.4 % 3.1 % 31 % 
  b) between tubes (n=5) 2.9 % 7.2 % 4.0 % 11 % 
  c) storage 20°C 0,2,9 days  14 % 7.1 % 1.6 % 3.2 % 
Plasma, other batch     
  b) between tubes (n=8) 2.9 % 10.6 % 15 % 16 % 
  c) storage 20°C 0,2,9 days  8.7 % 6.6 % 56 % - 
  d) storage 37°C 0,2,9 days  16 % 25 % 45 % 31 % 
a whole blood (n=13) b three analysis during a four months period 
 
2.3 Methods used by participants 
2.3.1 Environmental matrices  
Table 4 shows method information of the analytical techniques applied for the analysis of the FT as supplied 
by the participants. Most laboratories applied the ion-pair extraction by Hansen et al. (Hansen et al., 2001), 
in some cases slightly adjusted for e.g. higher sample intakes. Only 4 laboratories have applied a different 
method. Lab 13, 33 and 38 have applied a simple methanol extraction, without application of an ion pairing 
agent. Laboratory 30 has applied acetonitrile extraction, followed by a clean-up step with Envi-Carb. 
Laboratory 36 applied a clean-up over silica gel (in addition to the ion-pair extraction method) for removal of 
residual lipids from the extract. No laboratory applied instrumental extraction techniques like accelerated 
solvent extraction (ASE). 
Concerning the separation and detection of the ions by MS, most laboratories applied triple quadrupole 
MS/MS. One laboratory (22) applied high resolution time of flight MS (TOF-MS), using exact mass 
determination. Three laboratories (15, 27 and 36) applied ion-trap MS, which can be used in MS/MS mode 
for the perfluorinated carboxylic acids (PFCAs) and PFOSA. For the perfluorinated sulfonates (PFSAs), the 
technique can only be applied in single MS mode, although collision energy can be applied to eliminate co-
eluting matrix components to a certain extent. Finally, 4 laboratories applied single quadrupole MS. 
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Nearly all laboratories quantified the levels of the target compounds by application of external (solvent 
based) calibration curves. Two laboratories applied matrix matched calibration curves. Laboratory 23 
applied standard addition quantification by spiking subsamples of the fish tissue at 3 levels prior to 
extraction of the tissue.  
Ten laboratories applied 13C-labeled PFOA or PFDA as procedural internal standard (added prior to 
extraction). This standard is in most cases used for correction of all compounds that were analysed. Some 
laboratories have used non labelled perfluorinated compounds such as 7H-PFHpA, PFNA, PFDoA and TH-
PFOS. Among others, lab 38 applied 3 different internal standards in order to resemble the native 
compounds in terms of molecular structure and functional groups: d5-N-ethyl-PFOSA was applied for PFOSA, 
13C-PFDA used as internal standard for the PFCAs and TH-PFOS used as internal standard for PFOS.  A small 
group of laboratories have not applied an internal standard at all. One laboratory (8) applied deuterated 
mecoprop as internal standard, which has a very different molecular structure compared to the target 
compounds. 
Some laboratories have reported blank values for some compounds (e.g. PFOS, PFOA), although only two 
labs (8 and 23) have corrected their results for the reported blank values. 
Nearly all laboratories have reported the sum of the branched and linear isomers. 
 
2.3.2  Human matrices 
A summary of the methods used by the participants is given in Table 5. Basically three extraction methods 
were used SPE, acetonitrile precipitation and ion-pair extraction. Regarding separation and detection 
technique most laboratories used LC coupled to triple quadrupole MS/MS. Two laboratories used high 
resolution TOF and single quadrupole MS. One laboratory analysed PFOA and PFNA by GC-NCI-MS. 
Quantification was performed by either using external standards in solvent or standards spiked to the matrix 
or a surrogate matrix. Nearly all laboratories used an internal standard. 13C2-PFOA was the internal standard 
used by most laboratories. Other standards used were 13C2-PFDA, native 7HPFHpA, PFHpA, PFDoDA, 
THPFOS, perfluoro-3,7-dimethyloctanoic acid and 18O2-labelled PFOS. Five laboratories reported that they 
experienced blank levels of some target compounds and corrected the results for this. Almost all 
laboratories quantified resolved isomers together with the peak of the linear compound. 
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Table 4. Method information for the analysis of the FT. 
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1 1-3 No - N.a.* na N.a. LC-ESI-MS/MS Unextracted 
2 >3 ? - N.a. na N.a. LC-ESI-MS/MS MMC 
5 ?  - 13C-PFOA -  LC-ESI-MS/MS Unextracted  
6 Recently No - 7H-PFHpA 13C-PFOA, 13C-PFDA Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
7 1-3 No - 13C-PFDA - Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
8 1-3 Only PFOS - Mecoprop (deuterated) - Secret LC-ESI-MS/MS Unextracted 
9 >3 No - - - Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
10 >3 No 5 TH-PFOS - Ion-pair, MTBE LC-ESI-MS/MS Unextracted? 
11 Recently No - - - Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
13 1-3 No 
4 (PFOS), 
6 (PFOA) - - 
MeOH extraction, divinylbenzene SPE 
clean-up LC-ESI-MS Unextracted 
15 Recently No - N.a. na N.a. LC-ESI-ITMS(/MS) Unextracted 
16 >3 No 2 13C-PFOA - Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
19 1-3 No 3 13C-PFOA - Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
20 1-3 No - - - Ion-pair, MTBE LC-ESI-MS Unextracted 
21 1-3 No - 13C-PFOA - Ion-pair, MTBE LC-ESI-MS Unextracted 
22 >3 No - 7H-PFHpA 13C2-DH-PFOA Ion-pair, MTBE LC-ESI-TOF-MS Unextracted 
23 >3 Partly - -? 7H-PFHpA Ion-pair, MTBE LC-ESI-MS/MS MMC 
25 1-3  - -? -? N.a. LC-ESI-MS/MS Unextracted 
26 1-3 No - ? -? Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
27 1-3 No - 13C-PFDA - Ion-pair, MTBE LC-ESI-ITMS(/MS) Unextracted  
28 Recently  - N.a. na N.a. LC-ESI-MS/MS Unextracted 
29 Recently No - PFDoA PFNA Ion-pair, MTBE LC-ESI-MS/MS Unextracted 
30 1-3 No - 13C-PFOA - AcN extraction, Envi-Carb clean-up LC-ESI-MS/MS Unextracted 
33 Recently No - PFNA, 13C-PFOA - MeOH extraction LC-ESI-MS/MS Unextracted 
35 >3 No 3 N.a. na N.a. LC-ESI-MS Unextracted 
36 1-3 No - 
13C-PFOA for PFCAs and 
7H-PFHpA for PFSAs - Ion-pair, MTBE, Silicagel clean-up LC-ESI-ITMS(/MS) Unextracted 
38 >3  ? 
TH-PFOS, 13C-PFDA and 
d5-N-ethyl-PFOSA 
d3-N-ethyl-PFOSA for 
PFOSA MeOH extraction LC-ESI-MS/MS Unextracted 
* N.a.: participant has not analysed fish tissue sample, information shown here concerns the fish liver extract method. MMC = matrix match calibration 
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Table 5. Method information for the analysis of plasma and whole blood. 
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2 >3 - - 
13C-PFOA, 
13C-PFDA 
13C-PF(hexyl-
ethanoic)A SPE (copolymer) LC-ESI-MS/MS MMC 
3 1-3 PFOA,PFNA, PFOS - 
PF(3,7-dimethyl-
octanoic)A - Ion-pair, MTBE LC-ESI-MS/MS Rabbit matrix 
5 ? ? ? ? ? ? ? ? 
10 >3 - 2 THPFOS - Ion-pair, MTBE LC-ESI-MS/MS Unextracted, 
12 >3 All compounds - 13C2-PFOA - 
PFOA&PFNA=Ion-pair, derivatization 
PFOS&PFBS=AcN precipitation 
PFOA&PFNA = GC-NCI-MS 
PFOS&PFBS = LC-ESI-MS/MS Unextracted, 
16 >3 - 2 13C-PFOA - Ion-pair, MTBE LC-ESI-MS/MS Unextracted, 
17 ? ? 6 ? ? ? LC-ESI-MS/MS ? 
22 >3 - - 7H-PFHpA 13C2-DH-PFOA Ion-pair, MTBE LC-ESI-TOF-MS Unextracted, 
23 >3 PFHpA,PFOA, PFDA, PFUnDA 2 - 7H-PFHpA Ion-pair, MTBE LC-ESI-MS/MS MMC 
24 1-3 - - PFHpA 7H-PFHpA SPE (C18) LC-ESI-MS Unextracted, 
25 1-3 All compounds - 13C-PFOA 11H-PFUnA AcN precipitation CapLC-ESI-MS/MS Unextracted, 
30 1-3 -  13C-PFOA - AcN precipitation LC-ESI-MS/MS Unextracted, 
31a 1-3 All compounds - 
13C-PFOA  
18O2-PFOS 
- SPE (copolymer) LC-ESI-MS/MS Unextracted, 
32 >3 - 2 13C-PFOA - AcN precipitation LC-ESI-MS/MS Rabbit matrix 
34 >3 - - 
13C2-PFOA  
18O2-PFOS 
- SPE (copolymer) LC-ESI-MS/MS MMC 
35 >3 - - 13C-PFOA - AcN precipitation LC-ESI-MS/MS Rabbit matrix 
b Lab 31 method denoted “off”. MMC = matrix match calibration
2.4 Statistical analysis of the data 
Interlaboratory study data can be evaluated by various tools. The data of this study is evaluated by 
determination of z-scores. Z-scores provide valuable information on the performance of the laboratories 
compared to others. A z-score gives an indication on the accuracy of a laboratory. Z-scores do not provide 
information on a laboratorys’ precision (repeatability or reproducibility) as this study was not designed to 
answer that question.  
For calculation of a z-score, a target (or assigned) value is required. In this study this value is statistically 
derived from the submitted data and is based on the majority of the submitted data. Classical statistics are 
not considered to provide a close estimation of the true value for a set of data with a large variance, as it is 
unable to counteract the contribution of outlying data. For example, for a pool of data with a number of 
outlying data, robust statistics has been widely employed to calculate the assigned (or true) value. However, 
this tool has the disadvantage of insufficient correction for outliers. 
In the early 2000’s, the Cofino Model Statistics has been developed which circumvents this problem (Wells 
et al., 2004). It is based on normal distribution assumptions and has the ability to identify clusters of values 
with a high degree of affinity. Less than values can also be taken into account when present in a dataset. 
This model does not eliminate or down-weight, but rather illustrates the distribution of the data. Employing 
the Cofino Model Statistics, clusters of data are being identified. The assigned value is calculated from the 
cluster that represents the greatest percentage of the data.  
The calculation of the z-scores of each participant is carried out according to the following formula:  
 
       (xl- X) 
Z=  ------------ 
        δ 
 
Z =  Z-score value 
xl =  Laboratory mean (if applicable, otherwise single determination) 
X =  Assigned value 
δ =  0.125  
 
The variance value is set at 0.125. A z-score of 2 corresponds to a variance of 25%, which is considered a 
target variance for analytical methods for organic micropollutants in e.g. environmental samples. As 
discussed above, setting the δ at 0.125 prevents the z-scores to be effected by a possible high variety (due 
to considerable outlying values in the dataset). This method is routinely applied in interlaboratory studies 
such as those organized by QUASIMEME (www.quasimeme.org).   
Z-scores have been calculated for PFOS, PFHxS, PFOA, PFHxA, PFDA, PFDoA and PFOSA, providing that >5 
observations from laboratories were submitted. For the remaining compounds, the data as submitted is 
listed, including basic statistics in Appendix 2 to Appendix 6.  Z-score and distribution plots can be also 
found there. The result of a laboratory is considered satisfactory when the z-score is ≤I2I, doubtful when the 
z-score is between I2I and ≤I3I and unsatisfactory when outside that range. The scale of the y-axis in the 
plots showed here is limited from z=-6 to z=+6. Some participants have reported the results in another unit 
than was requested in the report forms. In those cases, the results were recalculated in order to match with 
the requested units.  
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3. Results and discussion 
 
The submitted results from the participants can be found in Appendix 2 to Appendix 6. For all sample 
matrices almost all laboratories reported values for PFOS and PFOA and a lower number of participants 
reported levels for the other PFCs.  
The results and discussion will be focused on PFOA, PFOS and PFOSA. The remaining compounds will be 
only briefly discussed. Not all laboratories that submitted results for the determinands in the study standard 
submitted results for the other matrices. Thus the number of data for the determinands in the e.g. the 
plasma or fish extract was lower than that for the study standard and lowest for the whole blood and fish 
tissue.  
 
3.1 PFOS 
Figure 1 to Figure 6 show the z-score plots for PFOS in all matrices. The graphical representations clearly 
indicate that the level of agreement of most laboratories is fairly good when analysing PFOS in a simple 
matrix such as the study standard, but decreases with increasing complexity of the matrix. Table 6 shows 
the summary of performance of laboratories. It can be seen that the largest number of z-scores exceeding 
I2I were obtained for the fish tissue.  
Some laboratories have been producing consistent results. Lab 29 obtained negative z-scores for all 
matrices of –1.4 in the SS, a slightly worse –1.8 in the FLE, –5.8 in the FT, -5.3 for the water sample, -4.0 
for the HP and -6.5 for the HB. Lab 10 showed more variety: a z-score of 5.5 for the SS, 2.9 for the FLE, -
3.9 for the FT, -6.1 for water, and -5.4 for HP. 
 
Table 6. Summary of performance of laboratories for PFOS in various matrices. 
Matrix* SS FLE FT Water HB HP 
Spiked/assigned value 33.3/28.6 ng/ml 
45**/19.3 
ng/ml 
4.4**/36.5 
ng/g ww 
N.a./19.5 
ng/ml 
N.a./10.4 
ng/ml 
N.a./22 
ng/ml 
Satisfactory |z|<2 22/29*** 12/22 3/18 5/16 6/9 10/16 
Questionable 2<|z|<3 1/29 4/22 0/18 2/16 1/9 - 
Unsatisfactory |z|>3 6/29 6/22 15/18 9/16 2/9 6/16 
* SS: study standard; FLE: fish liver extract; FT: fish tissue; HB: human blood and HP: human plasma 
** Spike in addition to the natural contamination 
*** Number of labs/total submitted datasets 
 
Calibration and use of internal standards 
Concerning calibration, most laboratories employed unextracted curves, meaning that no matrix was 
involved in their calibration standards. Obviously, this works well for the SS, where 22 out of 29 laboratories 
are capable of good calibration (Figure 1). The assigned value (28.6 ng/ml) is slightly lower than the 
theoretical (spiked) concentration (33.3 ng/ml) in the SS. This shows that the majority of the laboratories 
are close to the theoretical value. However, individual laboratories such as lab 9 and 6 show a considerable 
negative bias, whereas lab 26, 10, 3 and 5 show a positive bias. Apart from general analytical variance due 
to the instrument, and dilution or concentration errors, there can be other reasons for these z-scores 
including not using an internal standard. Also, a different isomer pattern in the lab’s standard compared to 
the pattern in the SS may cause a deviating result. Laboratory 29, as discussed earlier, obtained 
consistently negative z-scores in all matrices of -1.4 to -6.5 which may be an indication for a systematic 
calibration error. Also, laboratories 9 and (to a lesser extent) 6 consequently show low z-scores for the SS, 
FLE and FT. Matrix matched calibration (MMC) instead of unextracted curves (or solvent based calibration: 
by standards dissolved in e.g. methanol) is regarded essential for an accurate quantification when matrix 
effects due to ion suppression or mass interference occur (Martin et al., 2004). This is shown by the FLE 
where the assigned value (19.3 ng/ml) is considerably lower than the spiked addition of PFOS (44.7 ng/ml). 
It should be noted that the actual level of PFOS is even higher as the FLE already contained PFOS prior to 
the additional spike of 44.7 ng/ml. This shows that the majority of the laboratories have not been capable 
of accurate quantification of PFOS (using unextracted curves) in the FLE due to matrix effects.  
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For all matrices, laboratory 23 applied MMC. The PFOS level reported by this lab in the FLE is 66 ng/ml, 
which may be closer to the true value than the level reported by the remaining laboratories. Concerning the 
HP and HB samples, lab 23 used MMC and reported high PFOS values for both matrices. The same 
extraction method was used by laboratory 2 who was also assigned a high z-score for the HP but a 
negative z-score for HB. Laboratories 3 and 35 used surrogate rabbit matrix for the plasma determination 
resulting in a high z-score for laboratory 3 and a z-score close to zero for laboratory 35.  The inconsistent 
results using MMC and surrogate matrix calibration when quantifying HP and HB in this study together with a 
relatively good agreement between the laboratories might indicate that human blood is less sensitive to 
matrix effects in electrospray ionisation compared to the FLE (Karrman et al., 2005).   
One-third of the participants (of the EM part) has used isotopically labelled PFCAs as internal standards. 
From the z-scores, it cannot be concluded that these laboratories have more accurate results than other 
laboratories. This may partially be caused by the fact that a PFCA type of labelled standard will behave 
differently during extraction (and clean-up) compared to PFOS. Therefore, the availability of a (13C-) labelled 
PFOS internal standard is very desirable to minimize (by correction) the effect of matrix effects on the final 
result. It should be noted however, that electro spray suppression may even be enhanced by application of 
such an internal standard.  
Some laboratories used native PFCs like TH-PFOS, PFDoA and PFNA as internal standard to correct for their 
target PFCs. However, these compounds can be found in real environmental samples and the application of 
these internal standards can lead to considerable analytical errors. TH-PFOS was detected at considerable 
amounts in the water sample (see Appendix 5), which has led to the negative bias of laboratory 10 which 
used TH-PFOS as internal standard. Laboratories are therefore advised to check their samples for the 
absence of these (or other native) PFCs prior to the application of these internal standards. 
 
Extraction and clean-up 
Concerning the FT, most laboratories have applied the ion-pairing method originally published by (Hansen et 
al., 2001). Although individual laboratories may have obtained good recoveries in their internal validation 
experiments, in the case of the FT, the agreement between the participating laboratories is rather poor with 
only 27% of the laboratories obtaining a satisfactory z-score less than 2 (absolute). This is merely an effect 
of their extraction (and the absence of a) clean-up procedure since the overall performance for only the 
instrument calibration is much better (75% having a satisfactory z-score). The methods used for human 
matrices seem acceptable in the perspective of around 60% satisfactory z-scores.  
 
Level of experience 
The participants were asked to provide information on the number of years experience (recently started, 1-3 
years of >3 years of experience). Principal component analysis (PCA) of the data did not reveal a relation 
between the level of experience and reported PFC levels in FLE, FT or WS. 
 
MS/MS versus MS 
Most laboratories used MS/MS for analysis of PFOS in the EM samples, which enables the detection of the 
daughter-ion m/z 80 and 99. Laboratories using single quadrupole MS (lab 20, 21 and 35) and those using 
ion-trap MS (15, 27 and 36) don’t have the ability of detecting a daughter ion and may suffer from mass 
interferences. The FLE data (Figure 2) does not show a specific bias of laboratories applying MS. These 
laboratories are not grouped together but are distributed over the dataset and have z-scores (except lab 
21) of <I2I. This does not exclude the occurrence of a mass interference, but other sources may have a 
stronger effect on the total analytical error. Concerning the FT, a single MS bias may have occurred as lab 
27, 36 and 21 have a positive bias compared to the assigned value (although lab 20 has a negative z-
score). However, several MS/MS laboratories have considerable z-scores of >6, which may be due to the 
matrix effect discussed above. The only laboratory using MS for the human matrices obtained z-scores <I2I 
for both plasma and whole blood. Mass interferences are not expected for the study standard. The MS 
laboratories are distributed over the dataset as are the MS/MS laboratories. As a general recommendation, 
MS laboratories are advised to check for possible bias due to mass and/or matrix interference. 
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Figure 1. z-score plot of PFOS in the SS. Figure 2. z-score plot of PFOS in the FLE. Figure 3. z-score plot of PFOS in the fish tissue. 
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Figure 4. z-score plot of PFOS in water. Figure 5. z-score plot of PFOS in HP. Figure 6. z-score plot of PFOS in HB. 
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3.2 PFOA 
Similar to PFOS, the number of submitted datasets reduces by increasing complexity of the matrix. Also, 
the agreement between laboratories decreases as more laboratories have obtained unsatisfactory z-scores 
with the more complex matrices (Figures 7-12).  
Table 7 shows the summary of performance of laboratories. The assigned value of PFOA in the SS is 7.8 
ng/ml, which is very close to the theoretical value of 8.4 ng/ml, showing that the calibration of the majority 
of the laboratories is under control. However, 10 laboratories have unsatisfactory z-scores and should 
critically study their calibration. Concerning the FLE, and the FT, assigned values are also close to the 
spiked values, although it should be noted that the true value is not exactly known as little amounts of PFOA 
may have been present in FLE and FT prior to the spiking. The agreement between laboratories for plasma 
and human blood is relatively good with a percentage of satisfactory z-scores similar or better compared to 
the study standard. 
 
Table 7. Summary of performance of laboratories for PFOA in various matrices. 
Matrix SS FLE FT Water HB HP 
Spiked/assigned value 77 / 8.4 ng/ml 
11.3* / 
12.3 ng/ml
9.7* / 10.2 
ng/g ww 
N.a. / 19.4 
ng/ml 
N.a./1.0 
ng/ml 
N.a./2.0 
ng/ml 
Satisfactory |z|<2 21/33** 10/25 5/20 4/18 8/11 11/18 
Questionable 2<|z|<3 2/33 5/25 6/20 1/18 0/11 2/18 
Unsatisfactory |z|>3 10/33 10/25 9/20 13/18 3/11 5/18 
* Spike in addition to the natural contamination 
** Number of labs/total submitted datasets 
 
Like with PFOS, laboratories tend not to show a consistent performance. Lab 15 obtained a z-score of –
0.59 in the SS but 9.0 in the FLE and 4.8 for water. Lab 9 obtained z-scores of 5.0 in the SS, –5.1 in the 
FLE and 40 in the water sample. Lab 30 has a large positive bias for whole blood, plasma and FLE but 
satisfactory/questionable results for SS and FT. Contrary to this, lab 38 has high z-scores of >6 for the SS, 
FLE and FT and 4.1 for water. In the same way obtained lab 32 high z-scores for SS, plasma and blood. 
This may suggest a systematical (calibration) error. In the long-term experience of QUASIMEME 
(www.quasimeme.org), a z-score of >6 is often caused by errors in units, concentration/dilution or 
calculation errors rather than intrinsic analytical methodology errors. Factors of 2, 5, 10 or 1000 are 
common for these type of extreme values (Wells et al., 2004).   
Compared to PFOS, more laboratories may be capable of producing satisfactory results for the fish tissue. 
This may be associated with the fact that many laboratories apply a PFCA type of internal standard (13C-
labelled PFOA, -PFDA, PFDoA or 7H-PFHpA) which resembles more closely the target compound. 
Laboratories using no internal standard at all have shown similar performance as those using an internal 
standard. It is not known if these laboratories applied some way of correction for losses during analysis.   
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Figure 7. Z-score plot of PFOA in the SS. Figure 8. Z-score plot of PFOA in the FLE Figure 9. Z-score plot of PFOA in the FT. 
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Figure 10. Z-score plot of PFOA in the water. Figure 11. Z-score plot of PFOA in the HP Figure 12. Z-score plot of PFOA in the HB 
 
   RIVO Report C070/05 
 18
3.3 PFOSA 
In the case of the SS and the FLE, the assigned value is close to the spiked value. Some laboratories have 
values reported close to this value, whereas laboratories with outlying values have reported values up to 
almost 10 times the assigned value (FLE, lab 9). For the FT, many laboratories are underreporting the 
PFOSA concentration. The spiked value is 49, whereas the assigned value is 20 ng/g ww. Lab 5 was 
closest to the assigned value (41.3 ng/g ww).   
 
A summary of the performance of laboratories is given in Table 8 and the z-scores are shown in Figure 13 
to Figure 17. Some laboratories (lab 19, 23 and 38) report consistently high z-scores of z>3 for all 
matrices. It is currently not known what the reason could be for the systematically high z-scores. The three 
laboratories are experienced; apply regular instrumentation, methods and internal standards (see Table 4). 
Lab 38 is the only lab applying a non-ionic internal standard (d5-N-ethyl-PFOSA), which may be an advantage 
(although not clear from the z-scores). Laboratory 23 has consistently high values for a wide range of 
compounds including PFOSA. This may be due to the fact that this laboratory used MMC. On the other hand, 
a systematic error leading to high values cannot be excluded. 
 
Table 8. Summary of performance of laboratories for PFOSA in various matrices. 
Matrix SS FLE FT Water HB 
Spiked/assigned value 61/52  ng/ml 
6.1/5.6  
ng/ml 
49*/20  
ng/g ww 
N.a/1.0  
ng/ml 
N.a./0.39 
ng/ml 
Satisfactory |z|<2 10/24** 6/18 3/14 4/10 3/5 
Questionable 2<|z|<3 4/24 0/18 1/14 0/10 1/5 
Unsatisfactory |z|>3 10/24 12/18 10/14 6/10 1/5 
* Spike in addition to the natural contamination 
**: Number of labs/total submitted datasets  
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Figure 13. Z-score plot of PFOSA in the SS. Figure 14. Z-score plot of PFOSA in the FLE Figure 15. Z-score plot of PFOSA in the FT 
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Figure 16. Z-score plot of PFOSA in the water. Figure 17. Z-score plot of PFOSA in the HB  
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3.4 Other PFCs 
Considerable number of laboratories has submitted data on other PFCs such as PFHxS, PFHxA, PFNA, PFDA 
and PFDoA. Data of these compounds have been analysed statistically and z-scores have been calculated 
which can be found in Appendix 2 to Appendix 6. 
Very limited data was provided for PFBA and PFDS. No (commercial) fully characterized standard exists for 
PFDS, which hampers the quantification of this compound. Therefore, these results should be regarded as 
indicative.  
For all PFCs with >5 observations basic statistical analysis has been performed, which can be found in 
above mentioned appendices. From these data, it is clear that in the water and FT sample generally the 
highest RSD values are observed for the PFCAs (114 to 236%), and the PFSAs (47-250%) as compared to 
the other matrices. It should be noted however that outliers have not been removed from the basic 
statistics (e.g. lab 21 in the FT sample). A factor of 100 between the lowest and the highest reported value 
is sometimes observed (e.g. PFNA and PFDA in the water sample). Since no addition of PFCs was made to 
the human matrices the result is limited to the natural occurring compounds in the blood samples. Except 
PFOS and PFOA, PFNA and PFHS were frequently found and reported with an agreement between 
laboratories comparable to the discussed PFOS and PFOA (RSD 29-64%). 
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4. Conclusions 
 
This first world-wide interlaboratory study has successfully evaluated the quality of the data reported by the 
participants in a range of environmentally relevant matrices.  
Considering the recent development of the methods there is a fair agreement of the laboratories for PFOA, 
PFOS and PFOSA in the study standard, the fish liver extract, the whole blood and plasma sample. On the 
other hand there is little agreement for these three compounds in fish tissue and water. Concerning the fish 
tissue, the extraction and (absence of) clean-up is a considerable source of error contributing significantly to 
the overall variance of the dataset.  
 
The results show that the interpretation of the z-scores should be carefully made. The z-score definitely 
identifies the laboratories with the highest level of agreement, but does not necessarily point out those 
laboratories which obtained the closest estimate to the true value. Some of the datasets might be skewed 
and consequently the assigned values obtained are not necessarily the closest estimates of the true values 
for these PFCs. This has been observed for PFOS and PFOSA in the FLE, where the assigned value was 
considerably lower than the spiked value. As a result, laboratories with a somewhat elevated z-score could 
actually have been closer to the theoretical value. 
One should be careful relating performance to (parts of) analytical methodology. The error of a final result is 
often the sum of errors from various sources. In other words, a bias can have multiple origins such as 
extraction and clean-up, use of internal standards, unextracted calibration curves and the (non) use of 
(isotope labelled) internal standards. Given the spread in the dataset, it is highly likely that in most 
laboratories more than one analytical condition is not under control. 
 
Sample pre-treatment, extraction and cleanup procedures of the more complex matrices like the fish tissue 
are probably the most important sources of error. Laboratories are therefore advised to carefully check the 
efficiency and selectivity of their extraction and clean-up methods. However, interference during analysis 
due to matrix effects (electrospray suppression, mass interference) can also be an important factor in 
causing variability and bias in the final result.   
 
The type of calibration may have a considerable effect on the final result. This may have been the cause for 
the low results compared to the spiked amount for PFOS in the fish liver extract. For the whole blood and 
plasma dataset, there are no indications that quantification with unextracted calibration curves produce 
different results from matrix matched curves.   
 
The development of certified reference materials of different matrices is urgently required as a 
complementary QA tool.  
 
This study has shown that an interlaboratory study for PFCs is an essential aspect of today’s QA methods 
for evaluation of the performance of various laboratories. Laboratories are encouraged to have a critical 
look at their method performance and use this opportunity for improving their analytical methods. This will 
certainly have a positive effect on the quality of the results reported for monitoring and environmental and 
human risk assessment.  
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5. Recommendations 
 
The participants of this study are advised to improve their performance through critically assess the quality 
of their methods.  
 
Authors of peer viewed publications generally have limited the analytical methodology part of a publication 
in order to save space for results and discussion. However, a detailed discussion on the quality assurance 
will certainly improve the quality of the publication. 
 
The organization of the 2nd world-wide interlaboratory study is recommended in order to continuously 
improve the PFC data quality. 
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Appendix 1: List of participants 
 
 
Given in table A1 is the participants affiliations and contact information. Also seen is what 
matrices the laboratories participated in.
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Table A1. Participants in the 1st worldwide interlaboratory study 
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Appendix 2: Results for study standard 
 
 
 
 
 
 
Study standard results in ng/ml are presented as they were reported from each laboratory. 
Average, median and standard deviation was calculated after removing “non detect” values 
and with as many digits the laboratories reported. Distribution figures are given for the 
compounds that were added to the standard solution. 
 
 
NObs > LOQ Number of observations above limit of quantification 
NObs < LOQ  Number of observations below limit of quantification 
Assigned value True value obtained using Cofino statistics  
- Not analysed 
ND Not detected 
NQ Not quantified 
< Less than 
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Table A2. Study standard results (ng/ml) 
La
b.
 c
od
e 
PF
O
S 
PF
O
A
 
PF
N
A
 
PF
B
S 
PF
O
SA
 
PF
H
xS
 
PF
H
xA
 
PF
H
pA
 
PF
D
A
 
PF
U
nA
 
PF
D
oA
 
PF
B
A
 
PF
D
S 
1 32.70 9 <1 - 64.2 - 21.60 3 8.3 17 4.3 - <2 
2 28.4 8.18 <0.130 37.0 79.2 25.1 11.0 <0.105 7.70 14.9 3.23 - - 
3 65 6.4 ND - - - 15 ND 6.8 16 4.5 - - 
5 59.1 8.3 ND - 8.4 - - - 10.9 21.7 6.6 - - 
6 16 6.5 < 0.4 - 40 15 - < 0.4 7.5 8.0 3.0 - - 
7 29.8 7.7 ND - 54.4 23.9 - ND 7.3 13.1 - - - 
8 23.02 12.05 ND - 55.44 22.22 8.67 ND 8.86 - - - - 
9 6.2 12.7 2.7 15.3 13.5 16.5 11.9 - 7.1 12.3 7.3 - 0.5 
10 49.8 9.7 - - 30.9 17.3 11.8 - - - - - - 
11 29.43 4.05 - - - - - - - - - - - 
12 31.2 8.4 <0.2 35.2 - - - - - - - - - 
13 NQ 12.5 ND - - - - - ND ND ND - - 
15 35 7.2 < LOQ 53 37 - 4.2 < LOQ 9.4 - 3.5 - - 
16 30.85 7.37 0.08 35.15 54.97 25.21 8.49 0.13 6.41 10.54 3.08 4.97 - 
17 24.4 7.4 ND - 35.3 - - - 7.1 - - - - 
19 36 46 - 7.1 690 31 - - - - 5.1 - - 
20 21.5 7.1 0.1 33.8 40.9 21.5 5.0 0.2 7.2 10.8 3.5 2.1 - 
21 24 5 <1.6 25 52 26 7 1.4 7 11 3 - - 
22 34.7 12.7 0.11 42.9 59.1 26.2 15.4 0.21 13.2 24.7 6.74 5.07 <0.01 
23 31.5 7.5 <0.5 48 87.5 24 9 <0.5 10 17 6.3 - 0.8 
24 28 7 0.3 36 73 20 7 - 8 11 <0.3 - <0.5 
25 32.9 7.88 0.18 44.1 65.4 23.6 8.69 - 9.53 18.4 8.2 - - 
26 49.7 40.8 38 38.2 58.2 34.4 15 LOD 13.8 56.6 19.9 17.8 9.2 
27 29.9 6.5 - 35.7 55.5 23.3 10.4 - 4.7 8.1 12.3 5.3 - 
28 29 9 <2 38 387 32 8 <2 9 46 65 - - 
29 22 9.2 - 53 - 30 12 0.58 6.4 15 - - - 
30 - 10 ND - - - 6.6 - 9.3 14 2.8 - - 
31 23.8 7.3 <0.1 22.1 35 10.5 - <0.4 6.8 14.5 4.3 - - 
32 - 12.27 - - - - - - - - - - - 
33 - 9.0 - - - - - - - - - - - 
35 26.7 7.73 <0.50 - - - - - - - - - - 
36 24 4 <3.7 37.2 29.8 21.4 8 - 5.9 6 <6.5 - - 
38 28.7 20.8 ND - 81.8 - - - 10.6 6 4.5 - - 
              
NObs > LOQ 29 33 7 18 24 20 20 6 25 22 20 5 3 
NObs < LOQ 1  19     10 1 1 3  3 
Spiked amount 33.3 8.4 - 47.3 60.9 24 17.8 - 13.5 17.3 3.8 4.3 - 
Assigned value 28.6 7.8 - - 51.5 23.6 9.0 - 7.7 - 4.1 - - 
Min 6.2 4.1 0.08 7.1 8.4 10.5 4.2 0.13 4.7 5.8 2.7 2.1 0.5 
max 65 46 38 53 690 34 22 2.8 14 57 65 18 9 
Average 32 11 5.2 35 91 23 10 0.76 8.3 17 8.8 7.1  
Median 29 8.2 0.15 37 55 24 8.9 0.21 7.7 14 4.5 5.1  
St. dev. 12 9.0 13 12 146 5.9 4.2 1.0 2.2 12 14 8.2  
RSD (%) 38 83 256 34 160 25 40 134 26 72 156 87  
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Appendix 3: Results for fish liver extract 
 
 
 
 
 
 
Fish liver extract results in ng/ml are presented as they were reported from each laboratory. 
Average, median and standard deviation was calculated after removing “non detect” values and 
with as many digits the laboratories reported. Distribution figures are given. 
 
 
NObs > LOQ Number of observations above limit of quantification 
NObs < LOQ  Number of observations below limit of quantification 
Assigned value True value obtained using Cofino statistics 
- Not analysed 
ND Not detected 
NQ Not quantified 
< Less than 
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Table A3. Overview of submitted results and statistical data for the FLE (ng/ml) 
Lab code PFBA PFHxA PFHpA PFOA PFNA PFDA PFUnA PFDoA PFBS PFHxS PFOS PFDS PFOSA 
1 - 17 11 18 1.7 9.8 4.8 20 - - 22 17 8.8 
5c* - - - 8.9 0.79 9.7 4 17.2   31.2  3 
6 - - < 0.4 10 0.6 8.8 1.5 16 - 13 13 - 4.6 
7 - - <LOD 13.1 <LOD 8.8 3.8 - - 17.4 18.8 - 3 
8 - 1.36 0 16.07 0.66 11.77 - - - 17.74 19.18 - 5.87 
9 - - - 4.5 0.7 2.4 1 5.5 4 5.4 2.7 0.5 1 
10 - 3 - 13.2 - - - - - 12.3 26.4 - 3.3 
11 - - - 8.32 - - - - - - 14.83 - - 
15c - - - 26.1 - < LOD - - < LOD - < LOD - 6.1 
16 22.06 1.3 0.11 12.18 0.81 8.19 2.48 12.75 5.4 19.16 22.16 - 4.67 
19 - - - 77 - - - 22 <0.39 13 15 - 53 
20 9.3 1.6 0.2 11.7 0.4 9.2 2.3 18.2 5.3 17.3 17.5 - 5 
21 - <7 1.4 8.7 <1.6 5.8 1.5 13 <15 20 14 - 27 
22 18.6 2.58 0.23 22.9 2.48 21.3 6.64 34.2 7.01 19 25.1 0.24 6.69 
23 - 0.63 <0.5 21 1.6 20 4.8 27 11 27 62 1.2 11 
25 - 0.84 - 13.7 1.08 28.6 11.2 54 3.61 16.6 23.9 - 10.4 
26 9.3 2.1 LOD 29.1 - 31.9 12.4 95.7 13.7 36.6 49.5 <LOD 9.7 
27 18.1 ND - 12.4 - 6.2 14.5 15.1 <LOD 18.2 17.8 - <LOD 
28 - <2 <2 11 <2 11 11 337 <5 15 11 - 24 
29 - 1.6 <0.2 10 VS** 7.6 1.9 IS** 5.5 16 15 - - 
30c  2.1 - 24.6 1.4 20.6 5.4 19 - - - - - 
33 - - - 19 - - - - - - - - - 
35 - - - 15.6 0.61 - - - - - 19.2 - - 
36 - <3.5 - 12.2 <3.7 15.7 <3.5 24.1 <3.0 16.6 23.9 - - 
38c - - - 40.6 - 8.4 3.2 38.8 - - 28.6 - 14.7 
NObs > LOQ  5 11 6 25 12 19 17 17 8 17 22 4 18 
NObs < LOQ  - 4 6 - 4 1 1 - 6 - 1 1 1 
Spiked amount 18 2.7 - 11 - 14 2.1 17 6.9 19 45 - 6.1 
Assigned value - 1.7 - 12.3 - 8.9 - 18.1 - 17.0 19.3 - 5.6 
Min 9.3 0.63 0 4.5 0.4 2.4 1 5.5 3.61 5.4 2.7 0.24 1 
Max 22.06 17 11 77 2.48 31.9 14.5 337 13.7 36.6 62 17.325 53 
Average 15.5 3.1 2.2 18.4 1.1 12.9 5.4 45.3 6.9 17.7 22.4  11.2 
Median 18.1 1.6 0.2 13.2 0.8 9.7 4.0 20.4 5.5 17.3 19.2  6.4 
St. dev. 5.8 4.7 4.4 14.6 0.6 8.0 4.2 78.1 3.6 6.6 12.7  12.6 
RSD 38 150 202 79 57 62 78 172 51 37 57  112 
* Submitted data converted to ng/ml, ** VS: volume standard, IS: internal standard 
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Appendix 4: Results for fish tissue 
 
 
 
 
 
 
Fish tissue results in ng/g ww are presented as they were reported from each laboratory. 
Average, median and standard deviation was calculated after removing “non detect” values and 
with as many digits the laboratories reported. Distribution figures are given. 
 
 
NObs > LOQ Number of observations above limit of quantification 
NObs < LOQ  Number of observations below limit of quantification 
Assigned value True value obtained using Cofino statistics 
- Not analysed 
ND Not detected 
NQ Not quantified 
< Less than 
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Table A4. Overview of submitted results and statistical data for FT (ng/g ww) 
Lab code PFBA PFHxA PFHpA PFOA PFNA PFDA PFUnA PFDoA PFBS PFHxS PFOS PFDS PFOSA 
5 - - - 9.9 0.9 1.5 1.6 5.7 - - 56.3 - 31.5 
6 - - <0.4 5.3 0.6 1.3 0.4 14 - 0.6 7.1 - 20 
7 - - - 1.7 <LOD <LOD <LOD - - 12.6 38.8 - 21.8 
8 - 0.18 0.24 13.85 0.68 2.99 - - - 22.01 63.32 - 30.2 
9 - 36.2 - 44.2 48.2 44.1 42.6 53.2 8.1 7.1 5.9 35.3 3.4 
10c* - 4.2 - 13 - - - - - 4.7 18.3 - 17.0 
11 - - - 14.02 - - - - - - 69.64 - - 
13 - - - 12.5 <LOD <LOD <LOD <LOD - - "detected'' - - 
16 - <0.25 <0.25 7.78 0.99 1.9 1.09 26.11 16.46 16.36 66.76 - 29.83 
19 - - - 13 - - - 17 <0.54 3.0 20 - 230 
20 1.91  0.01  0.06  0.54  0.15  0.19  0.07  1.50  0.95  1.13  4.41  - 1.97  
21 - 337 13 204 272 <0.5 90 54 23 54 295 - 112 
22 29.7 <0.67 0.32 9.85 1.17 2.64 1.03 18.3 16.0 13.0 27.0 0.08 26.6 
23 - <3 1.3 9.2 1.4 3.8 2 191 22 26 128 <0.5 207 
26 'blank'' <LOD 1.9 2.7 70.8 0.63 0.39 7.9 2.3 29.5 2.8 <LOD 3.6 
27 41 <LOD -  - 29 <LOD 74 <LOD 21 54 - <LOD 
29 - 1 3.1 3.8 VS** <1.0 <0.5 IS** 7.7 6.3 9.63 - - 
30 - <LOD - 13 1.8 3.7 2 47 - - - - - 
33 - - - 24 - - - - - - - - - 
36 - <1.7 - 13 <1.9 4.0 <1.8 21.0 22 24 77 - - 
38 - - - 21.3 0.9 1.5 2.1 26.9 - - 41.1 - 110.2 
NObs > LOQ  3 6 7 20 12 13 11 14 9 15 18 2 14 
NObs < LOQ  - 7 2 1 3 4 5 1 2 - - 2 1 
Spiked amount 50 - - 9.7 - - - 40 21 22 4.4 - 49 
Assigned value  1.0  10.2  2.2 - 19.6 - 13.2 36.5 - 20.3 
Min 1.91 0.01 0.06 0.54 0.15 0.19 0.07 1.5 0.95 0.6 2.8 0.08 1.97 
Max 41 337 13 204 272 44.1 90 191 23 54 295 35.3 230 
Average  63.2 2.8 21.8 33.3 7.5 13.1 39.9 13.2 16.1 54.7  60.4 
Median  2.6 1.3 12.8 1.1 2.6 1.6 23.6 16.0 13.0 40.0  28.2 
St. dev.  135.1 4.5 43.9 78.7 13.3 28.5 48.4 8.6 14.2 68.5  75.5 
RSD %  214 161 201 236 178 218 121 65 88 125  125 
* Converted to ng/g ww, ** VS: volume standard IS: internal standard        
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Appendix 5: Results for water 
 
 
 
 
 
 
Water results in ng/l are presented as they were reported from each laboratory. Average, median 
and standard deviation was calculated after removing “non detect” values and with as many digits 
the laboratories reported. Distribution figures are given for all compounds. 
 
 
NObs > LOQ Number of observations above limit of quantification 
NObs < LOQ  Number of observations below limit of quantification 
Assigned value True value obtained using Cofino statistics 
- Not analysed 
ND Not detected 
NQ Not quantified 
< Less than 
 
 
 
 
   RIVO Report C070/05 
 
Table A5. Overview of submitted results and statistical data for the water sample (ng/l) 
Lab code PFBA PFHxA  PFHpA PFOA  PFNA  PFDA  PFUnA  PFDoA PFBS  PFHxS  PFOS  PFDS PFOSA TH-PFOS 
1c* - 94.40 17.10 44.10 9.40 6.40 14.10 6.50 - - 112.00 16.40 8.10  
2 - 4.02 2.48 20.0 1.45 1.09 <0.506 <0.361 16.3 5.02 16.6 - 1.46  
6 - - < 4 11 < 2 < 2 < 2 < 2 - < 4 21 - < 1  
7 - - IS** 15.2 n.d. 0.3 0.3 - - 5.6 20.7 - 0.8  
8 - 4.2 2.11 18.75 0.55 0.78 - - - 4.45 16.66 - 1.42  
9 - 233.5 - 117.5 62.0 29.6 37.0 43.8 - 232.0 105.0 39.4 2.31  
10 - < 0,5 - 3.4 - - - - - < 0,5 4.7 - < 0,5  
13 - - - 10 <LOD <LOD <LOD <LOD - - - - -  
15 - - - 31 - < LOD - - 16 - 56 - < LOD  
16 22.86 5.04 2.09 17.1 0.46 0.31 <0.04 <0.04 13.18 6.63 24.3 - 0.8  
19 - - - 190 - - - LQL 8.4 7.6 26 - 4.0  
20 1.2  10.7  1.9  10.8  0.5  0.4  <LOD <LOD 30.6  4.3  13.0  - 1.2   
22 <0.02 8.23 3.74 29.9 2.76 1.50 0.13 <0.03 17.0 8.01 29.8 0.23 0.94 186 
23  - - 30 0.9 2.5 0.5 <0,2 - 7.7 47 3.1 4 100 
25 - 44.7 - 44.5 5.9 10.7 < LOD < LOD 27.4 10.7 41.7 - < LOD  
28c - <2000 <2000 <2000 <2000 <2000 <2000 <2000 <5000 <5000 <5000 - <20000  
29 - 6.1 4.2 13 VS** <1.0 <1.0 IS** 8.7 6.8 6.6 - -  
30 - - - - <LOD <LOD <LOD <LOD - - - - -  
33c - - - 110 - - - - - - - - -  
38 - - - 29.5 2.6 <LOD <LOD <LOD - - 6.9 - -  
NObs > LOQ  2 9 7 18 10 10 5 2 8 11 16 4 10 2 
NObs < LOQ  1 2 2 1 4 7 10 11 1 3 1 - 5 - 
Spiked amount - - - - - - - - - - - - - - 
Assigned value - 5.0 - 19.4 - 0.42 - - - 6.3 19.5 - 1.0 - 
Min 1.2 4.02 1.9 3.4 0.46 0.3 0.13 6.5 8.4 4.3 4.7 0.23 0.8 100 
Max 22.86 233.5 17.1 190 62 29.6 37 43.8 30.6 232 112 39.4 8.1 186 
Average  45.7 4.8 41 8.7 5.4 10.4  17.2 27.2 34.2  2.5  
Median  8.2 2.5 24.8 2.0 1.3 0.5  16.2 6.8 22.7  1.4  
St. dev.  76.6 5.5 49 19.0 9.2 16.0  8.0 68.0 32.4  2.3  
RSD  168 114 118 219 171 154  47 250 95  92  
* Submitted data converted to ng/l, ** VS: volume standard, IS: internal standard 
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Appendix 6: Results for human matrices 
 
 
 
 
 
 
Plasma and whole blood results in ng/ml are presented as they were reported from each 
laboratory. Statistics and distribution figures are given for a compound if ≥5 laboratories 
submitted results above their limit of quantification. Average, median and standard deviation were 
calculated after removing “non detect” values and with as many digits the laboratories reported.  
 
 
NObs > LOQ Number of observations above limit of quantification 
NObs < LOQ  Number of observations below limit of quantification 
Assigned value True value obtained using Cofino statistics 
- Not analysed 
ND Not detected 
NQ Not quantified 
< Less than 
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Table A6.1 Plasma results (ng/ml) 
La
b.
 c
od
e.
 
PF
O
S 
PF
O
A
 
PF
N
A
 
PF
H
xS
 
PF
O
SA
 
PF
B
S 
PF
D
S 
PF
H
pA
 
PF
D
A
 
PF
U
nA
 
2 34.9 2.11 0.909 0.616 <0.029 <0.342 - <0.043 0.281 0.309 
3 31. 1.19 0.77 - - - - ND ND ND 
5 21.9 1.5 <0.4 - <0.7 - - - <0.4 <0.1 
10 7.1 0.5 - <0.05 <0.05 - - - - - 
12 31 2.04 0.52 - - 0.29 - - - - 
16 19.92 1.5 0.38 0.78 <0.01 0.02 - <0.05 <0.05 0.14 
17 25.3 2.0 0.62 - ND - - - ND - 
22a 22.2 3.63 1.14 1.38 <0.16 <0.01 0.22 0.09 0.31 0.22 
23a 31 2.4 0.72 1.9 0.62 <2.4 1.7 0.68 0.59 0.44 
24 22 1.4 0.5 1.6 0.6 <2 <0.5 - <0.2 <0.1 
25 24.8 2.03 0.29 1.7 ND ND - - 0.63 0.14 
29 11 2 - 4 - <0.2 - 0.55 <0.2 <0.1 
30 - 5.2 NQ - - - - - NQ NQ 
31b 18.8 1.9 NQ 1.1 <0.2 0.5 - <0.3 <0.3 <0.3 
31c 19.9 1.8 0.4 0.8 0.1 0.5 - <0.4 0.2 0.2 
32 - 2.8 - - - - - - - - 
34 22.7 2.2 - 1.3 - <1.0 - - - - 
35 22.7 1.8 1.25 - - - - - - - 
           
NObs > LOQ  16 18 11 10 3 4 2 3 5 6 
NObs < LOQ  - - 1 1 8 7 1 5 7 5 
Spiked amount - - - - - - - - - - 
Assigned value 22.2 2.0 - 1.2 - - - - - - 
Min 7.1 0.50 0.29 0.62 0.1 0.02 0.22 0.09 0.2 0.14 
max 34.9 5.2 1.25 4 0.62 0.5 1.7 0.68 0.63 0.44 
Average 23 2.1 0.62 1.5     0.43 0.23 
Median 23 2.0 0.57 1.3     0.45 0.20 
St. dev. 7.2 1.1 0.26 0.97     0.21 0.12 
RSD (%) 32 51 42 64     49 54 
 
 
a Reported values transformed from ng/g to ng/ml using average density of human plasma 1.03 g/ml (Benson, 
Katherine. MCAT review. Emory University.1999). 
b Lab 31 method denoted “off” 
c Lab 31 method denoted “on” 
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Table A.6.2 Whole blood results (ng/ml) 
La
b.
 c
od
e.
 
PF
O
S 
PF
O
A
 
PF
N
A
 
PF
H
xS
 
PF
O
SA
 
PF
B
S 
PF
D
S 
PF
H
pA
 
PF
D
A
 
PF
U
nA
 
Lab 2 9.09 2.15 0.49 1.63 0.305 <0.006 - 0.116 0.239 0.275 
Lab 5 9.3 1.7 <0.4 - <0.7 - - - <0.4 <0.1 
Lab 12 10.6 2.13 0.19 - - <2 - - - - 
Lab 16 7.3 1.62 0.29 0.66 0.24 <0.02 - <0.1 0.11 <0.2 
Lab 17 10.0 1.8 0.53 - ND - - - ND - 
Lab 22a 11.8 4.06 0.87 1.17 0.45 <0.01 0.02 0.22 0.47 0.26 
Lab 23a 24 1.4 0.5 1.4 1.6 <2.4 <0.5 <0.6 0.5 <0.3 
Lab 24 10 2 0.4 1.5 0.5 <2 <0.5 - <0.1 <0.1 
Lab 29 1.8 1.4 - 0.99 - <0.2 - 0.54 <0.2 <0.1 
Lab 30 - 3.6 NQ - - NQ - - NQ ND 
Lab 32 - 2.62 - - - - - - - - 
           
NObs > LOQ  9 11 7 6 5 0 1 3 4 2 
NObs < LOQ  - - 1  2 7 2  4 6 
Spiked amount - - - - - - - - - - 
Assigned value 9.8 1.8 - 1.4 0.39 - - - - - 
Min 1.8 1.4 0.19 0.66 0.24   0.12 0.11 0.26 
max 24 4.1 0.87 1.63 1.6   0.54 0.5 0.28 
Average 10.4 2.2 0.47 1.23 0.62      
Median 10.0 1.9 0.49 1.29 0.45      
St. dev. 5.9 0.91 0.22 0.36 0.56      
RSD (%) 56 42 46 29 90      
 
 
a Reported values transformed from ng/g to ng/ml using average human whole blood density 1.060 g/ml (“Blood” Funk 
and Wagnalls Encyclopedia. 1985:157). 
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